Well Being

Americans woke up this morning to the news that the FDA and the CDC have recommended a pause on the Johnson & Johnson COVID vaccine out of "an abundance of caution" while they review 6 incidences of rare blood clotting issues out of the 6.8 million J & J vaccines administered in the U.S.

Let's be super clear about the numbers here. Six out of 6.8 million. That means, of the people who have received the Johnson & Johnson vaccine since its February 27th emergency use authorization, 0.000088% of recipients have reported encountering this rare blood clotting issue. Literally less than one in a million.

On the flip side, some people are trying to compare these rare clots with the increased risk of blood clots in pregnancy and for those taking birth control pills, but this particular combination of clots and low platelets can't be treated the way clots normally are treated, which the CDC and FDA say is part of the reason for the pause—to alert doctors to treat any of these rare issues properly.

Keep Reading Show less